- Home
- BDRX vs RVYL Comparison
BDRX vs RVYL Comparison
Compare BDRX & RVYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BDRX | RVYL |
|---|---|---|
| Founded | 2000 | 2007 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8M | 9.3M |
| IPO Year | 2015 | 2008 |
Fundamental Metrics
Financial Performance| Metric | BDRX | RVYL |
|---|---|---|
| Price | $0.83 | $5.52 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 106.1K | 10.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 60.34 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $55,998,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $297.49 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.79 | $0.14 |
| 52 Week High | $11.88 | $8.55 |
Technical Indicators
Market Signals| Indicator | BDRX | RVYL |
|---|---|---|
| Relative Strength Index (RSI) | 28.25 | 49.18 |
| Support Level | $0.79 | $5.34 |
| Resistance Level | $1.29 | $6.10 |
| Average True Range (ATR) | 0.07 | 0.35 |
| MACD | 0.04 | -0.08 |
| Stochastic Oscillator | 4.57 | 26.26 |
Price Performance
Historical ComparisonAbout BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
About RVYL Ryvyl Inc.
Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.